E. Fognani

发表

Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.

P. Cattani, G. Rapaccini, N. de Matthaeis, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection

F. Izzo, A. Mangia, F. Buonaguro, 2014, BioMed research international.

Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemia

L. Petraccia, A. Zignego, M. Fiorilli, 2016, Hepatology.

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact

A. Zignego, C. Giannini, L. Gragnani, 2012, Journal of Translational Medicine.

Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study

A. Fabbrizzi, B. Boldrini, A. Zignego, 2015, Hepatology.

Value of IL28B genotyping in patients with HCV‐related mixed cryoglobulinemia: results of a large, prospective study

P. Caini, A. Zignego, A. Zignego, 2013, Journal of viral hepatitis.

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.

C. Tinelli, S. Ludovisi, M. Mondelli, 2011, Autoimmunity reviews.

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy

A. Fabbrizzi, B. Boldrini, A. Zignego, 2015, Case reports in immunology.

Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.

C. Tinelli, A. de Silvestri, S. Ludovisi, 2015, Autoimmunity reviews.

Ef ﬁ cacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

C. Tinelli, S. Ludovisi, M. Mondelli, 2015 .

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.

P. Caini, A. Zignego, G. Laffi, 2011, Arthritis and rheumatism.

Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response

R. Bruno, M. Morfini, E. Santagostino, 2014, Thrombosis and Haemostasis.

Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies

F. Conti, P. Andreone, A. Zignego, 2015, Hepatology International.

Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia

P. Caini, A. Zignego, G. Laffi, 2013, PloS one.

Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong

A. Zignego, L. Gragnani, E. Fognani, 2013 .

F. Izzo, F. Buonaguro, S. Russi, 2016, Oncotarget.

Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases

M. Libra, S. Bagnoli, I. Piaceri, 2017, Oncotarget.

Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?

A. Zignego, L. Gragnani, E. Fognani, 2013, World journal of gastroenterology.

Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.

Monica Monti, L. Petraccia, A. Fabbrizzi, 2017, Current drug targets.

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.

A. Fabbrizzi, B. Boldrini, P. Caini, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

MicroRNA expression in hepatitis C virus-related malignancies: A brief review.

A. Zignego, L. Gragnani, E. Fognani, 2015, World journal of gastroenterology.

IgG3 subclass: A possible trigger of mixed cryoglobulin cascade in hepatitis C virus chronic infection.

G. Rapaccini, A. Zignego, C. Napodano, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Hepatitis C-associated B-cell non-Hodgkin lymphomas: the emerging role of miRNA-26b.

A. Zignego, L. Gragnani, E. Fognani, 2013, Journal of hepatology.

454 microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA

P. Caini, A. Zignego, G. Laffi, 2013 .

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.

P. Caini, A. Zignego, G. Laffi, 2011, Arthritis & Rheumatism.